Literature DB >> 16779503

Use of heparin upon reoperation in a pediatric patient with heparin-induced thrombocytopenia after disappearance of antibodies.

Christian Schreiber1, W Dietrich, S Braun, M Kostolny, A Eicken, R Lange.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16779503     DOI： 10.1007/s00392-006-0392-9

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  10 in total

1.  One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II.

Authors:  A Koster; O Meyer; T Fischer; M Kukucka; T Krabatsch; M Bauer; H Kuppe; R Hetzer
Journal:  J Thorac Cardiovasc Surg       Date:  2001-12       Impact factor: 5.209

2.  Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia.

Authors:  B Pötzsch; W P Klövekorn; K Madlener
Journal:  N Engl J Med       Date:  2000-08-17       Impact factor: 91.245

3.  Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4)

Authors:  O Meyer; A Salama; N Pittet; P Schwind
Journal:  Lancet       Date:  1999-10-30       Impact factor: 79.321

4.  Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution.

Authors:  S Nand; W Wong; B Yuen; A Yetter; E Schmulbach; S Gross Fisher
Journal:  Am J Hematol       Date:  1997-09       Impact factor: 10.047

5.  [Heparin-induced thrombocytopenia type II with early aortocoronary bypass occlusion and stent thrombosis after PTCA of the RCA--treatment with lepirudin (Refludan) and abciximab (Reo pro) during recanalization of the RCA].

Authors:  F C Laubenthal; B Grosch; G Szurawitzki; G V Sabin
Journal:  Z Kardiol       Date:  1999-02

6.  A 14-year study of heparin-induced thrombocytopenia.

Authors:  T E Warkentin; J G Kelton
Journal:  Am J Med       Date:  1996-11       Impact factor: 4.965

7.  Outcomes of mitral valve replacement in children: a competing-risks analysis.

Authors:  Fatemeh Kojori; Rui Chen; Christopher A Caldarone; Sandra L Merklinger; Anthony Azakie; William G Williams; Glen S Van Arsdell; John Coles; Brian W McCrindle
Journal:  J Thorac Cardiovasc Surg       Date:  2004-11       Impact factor: 5.209

Review 8.  Heparin-induced thrombocytopenia and cardiac surgery.

Authors:  Theodore E Warkentin; Andreas Greinacher
Journal:  Ann Thorac Surg       Date:  2003-12       Impact factor: 4.330

9.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

Review 10.  Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature.

Authors:  Anne F Klenner; Norbert Lubenow; Ricarda Raschke; Andreas Greinacher
Journal:  Thromb Haemost       Date:  2004-04       Impact factor: 5.249
  10 in total
  1 in total

Review 1.  [Direct thrombin inhibitors: pharmacology and application in cardiovascular anesthesia].

Authors:  S A Kozek-Langenecker
Journal:  Anaesthesist       Date:  2008-06       Impact factor: 1.041
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.